iconoclast - I whole heartedly agree with you. In coming up with the number of $16.8 billion US$ using $2,000 per patient per year it gives a C$90.00 per share valuation for cardio only. If I multiplied that by 5 to give me a C$450.00 valuation for cardio only, many may be asking what it is that I have been stoking my pipe with. If I am correct and the CKD and demenia markets are both larger than the cardio market, that would put the valuation at over C$1,000 per share. And that, is to good to be true, today.

tada